Natasha Savoie

Statistics

Publications

Citations

1.2K

H-Index

Active since

2009

Affiliations

United States Food and Drug Administration(Current)

Pfizer (United States)

Bristol-Myers Squibb (United States)

GlaxoSmithKline (United States)

Health Canada

Natasha Savoie is an author at United States Food and Drug Administration specializing in bioanalytical methodology, pharmacy, and bioanalytical method validation.

Publications per year

2009–2022

Publications

2010 White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Guidance

Natasha Savoie, Fabio Garofolo, Peter van Amsterdam et al. · Bioanalysis · 2010 · 122 citations

Pharmacy, Chemistry, Pharmaceutical Analysis +15

The 2nd Calibration and Validation Group Workshop on Recent Issues in Good Laboratory Practice Bioanalysis

Natasha Savoie, Brian Booth, T Hyman Bradley et al. · Bioanalysis · 2009 · 94 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Recommendations On: Internal Standard Criteria, Stability, Incurred Sample Reanalysis and Recent 483s by the Global CRO Council for Bioanalysis

Steve Lowes, Jim Jersey, Ronald E. Shoup et al. · Bioanalysis · 2011 · 88 citations

Pharmacy, Toxicology, Analytical Chemistry +13

2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 3 – Lba, Biomarkers and Immunogenicity)

Lakshmi Amaravadi, An Song, Heather Myler et al. · Bioanalysis · 2015 · 74 citations · Full text

Pharmacy, Biomedical Sciences, Pharmaceutical Analysis +16

2017 White Paper on Recent Issues in Bioanalysis: A Global Perspective on Immunogenicity Guidelines & Biomarker Assay Performance (Part 3 – Lba: Immunogenicity, Biomarkers and PK Assays)

Shalini Gupta, Susan Richards, Lakshmi Amaravadi et al. · Bioanalysis · 2017 · 67 citations · Full text

Pharmacy, Biomedical Sciences, Biopharmaceutics +16

1–5 of 28